Chihiro Shimazaki

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano et al. · PubMed · 1999 · 765 citations

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · The Lancet · 2019 · 620 citations

Hematological Malignancy, Medicine, Immunology +6

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 609 citations · Full text

Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia

Hitoshi Kiyoi, T Naoe, S Yokota et al. · Leukemia · 1997 · 342 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +8

Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.

Tomoki Naoe, Kunihiko Takeyama, Toshiya Yokozawa et al. · PubMed · 2000 · 190 citations

Metabolic Activation, Genetics, Mixed-phenotype Acute Leukemia +16